1. Home
  2. NNDM vs PROK Comparison

NNDM vs PROK Comparison

Compare NNDM & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.57

Market Cap

368.1M

Sector

Technology

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.93

Market Cap

331.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
PROK
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.1M
331.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
NNDM
PROK
Price
$1.57
$1.93
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.40
AVG Volume (30 Days)
1.4M
508.7K
Earning Date
03-31-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1075.00
52 Week Low
$1.31
$0.46
52 Week High
$2.32
$7.13

Technical Indicators

Market Signals
Indicator
NNDM
PROK
Relative Strength Index (RSI) 30.10 37.13
Support Level $1.47 $1.71
Resistance Level $1.67 $2.58
Average True Range (ATR) 0.08 0.16
MACD -0.04 -0.04
Stochastic Oscillator 4.98 9.15

Price Performance

Historical Comparison
NNDM
PROK

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: